Similar articles for PMID: 35618428

Year	Number of Results
1998	1
1999	1
2002	1
2004	1
2005	2
2006	2
2007	3
2008	4
2009	2
2010	2
2011	2
2012	1
2013	4
2014	7
2015	8
2016	15
2017	21
2018	13
2019	11
2020	14
2021	9
2022	12
2023	4
2024	0

1

Volumetric Measurement of Relative CBV Using T1-Perfusion-Weighted MRI with High Temporal Resolution Compared with Traditional T2*-Perfusion-Weighted MRI in Postoperative Patients with High-Grade Gliomas.

Seo M, Ahn KJ, Choi Y, Shin NY, Jang J, Kim BS. Seo M, et al. AJNR Am J Neuroradiol. 2022 Jun;43(6):864-871. doi: 10.3174/ajnr.A7527. Epub 2022 May 26. AJNR Am J Neuroradiol. 2022. PMID: 35618428 Free PMC article.

2

Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study.

Scola E, Desideri I, Bianchi A, Gadda D, Busto G, Fiorenza A, Amadori T, Mancini S, Miele V, Fainardi E. Scola E, et al. Radiol Med. 2022 Jun;127(6):664-672. doi: 10.1007/s11547-022-01470-z. Epub 2022 Apr 20. Radiol Med. 2022. PMID: 35441970

3

Comparative evaluation of cerebral gliomas using rCBV measurements during sequential acquisition of T1-perfusion and T2*-perfusion MRI.

Saini J, Gupta RK, Kumar M, Singh A, Saha I, Santosh V, Beniwal M, Kandavel T, Cauteren MV. Saini J, et al. PLoS One. 2019 Apr 24;14(4):e0215400. doi: 10.1371/journal.pone.0215400. eCollection 2019. PLoS One. 2019. PMID: 31017934 Free PMC article.

4

Utility of Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging and ¹¹C-Methionine PET/CT for Differentiation of Tumor Recurrence from Radiation Injury in Patients with High-Grade Gliomas.

Qiao Z, Zhao X, Wang K, Zhang Y, Fan D, Yu T, Shen H, Chen Q, Ai L. Qiao Z, et al. AJNR Am J Neuroradiol. 2019 Feb;40(2):253-259. doi: 10.3174/ajnr.A5952. Epub 2019 Jan 17. AJNR Am J Neuroradiol. 2019. PMID: 30655259 Free PMC article.

5

Association between Tumor Acidity and Hypervascularity in Human Gliomas Using pH-Weighted Amine Chemical Exchange Saturation Transfer Echo-Planar Imaging and Dynamic Susceptibility Contrast Perfusion MRI at 3T.

Wang YL, Yao J, Chakhoyan A, Raymond C, Salamon N, Liau LM, Nghiemphu PL, Lai A, Pope WB, Nguyen N, Ji M, Cloughesy TF, Ellingson BM. Wang YL, et al. AJNR Am J Neuroradiol. 2019 Jun;40(6):979-986. doi: 10.3174/ajnr.A6063. Epub 2019 May 16. AJNR Am J Neuroradiol. 2019. PMID: 31097430 Free PMC article.

6

Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.

Hu LS, Kelm Z, Korfiatis P, Dueck AC, Elrod C, Ellingson BM, Kaufmann TJ, Eschbacher JM, Karis JP, Smith K, Nakaji P, Brinkman D, Pafundi D, Baxter LC, Erickson BJ. Hu LS, et al. AJNR Am J Neuroradiol. 2015 Dec;36(12):2242-9. doi: 10.3174/ajnr.A4451. Epub 2015 Sep 10. AJNR Am J Neuroradiol. 2015. PMID: 26359151 Free PMC article.

7

Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.

Xu Q, Liu Q, Ge H, Ge X, Wu J, Qu J, Xu K. Xu Q, et al. Medicine (Baltimore). 2017 Dec;96(50):e9332. doi: 10.1097/MD.0000000000009332. Medicine (Baltimore). 2017. PMID: 29390403 Free PMC article.

8

Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.

Qu Y, Kong D, Wen H, Ou X, Rui Q, Wang X, Lin DD, Qin Q, Wen Z. Qu Y, et al. Eur Radiol. 2022 May;32(5):2976-2987. doi: 10.1007/s00330-021-08406-7. Epub 2022 Jan 23. Eur Radiol. 2022. PMID: 35066634

9

Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.

Tietze A, Boldsen JK, Mouridsen K, Ribe L, Dyve S, Cortnum S, Østergaard L, Borghammer P. Tietze A, et al. Acta Radiol. 2015 Sep;56(9):1135-44. doi: 10.1177/0284185114550020. Epub 2014 Sep 30. Acta Radiol. 2015. PMID: 25270372

10

Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.

Lee MK, Park JE, Jo Y, Park SY, Kim SJ, Kim HS. Lee MK, et al. Eur Radiol. 2020 Feb;30(2):844-854. doi: 10.1007/s00330-019-06395-2. Epub 2019 Aug 24. Eur Radiol. 2020. PMID: 31446467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year